©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 7, 2009; 15(37): 4686-4694
Published online Oct 7, 2009. doi: 10.3748/wjg.15.4686
Published online Oct 7, 2009. doi: 10.3748/wjg.15.4686
Table 3 Risks or hazards of allogeneic blood transfusion
| Acute transfusion reactions |
| Immunologic reactions |
| Acute haemolytic reaction (or THRs) |
| Febrile non-haemolytic reaction |
| Allergic reactions: Urticaria and anaphylaxis |
| Acute non-cardiogenic pulmonary edema: TRALI |
| Alloimmunization with acute platelet destruction |
| Non-immunologic reactions |
| Bacterial contamination |
| TACO |
| Hypotensive reaction |
| Non-immunologic haemolysis |
| Others: Hypocalcemia, hyperkalemia (cardiac arrest), hypothermia, hyperglycemia, etc |
| Delayed transfusion reactions |
| Immunologic reactions |
| Delayed haemolytic reaction |
| Alloimmunization against blood cell antigens (also platelets and leukocytes) |
| Graft vs host disease |
| Transfusion-related immunomodulation |
| Post-transfusion purpura |
| Non-immunologic reaction |
| Transfusion-transmitted infection: viruses (Hepatitis A, B, C, E, VIH 1-2, West Nile virus, HTLV I-II, Citomegalovirus, Virus Herpes viridae, TTV, SEN-1, SARS, etc), protozoa (malaria, babe biosis, Chagas disease, etc), prion (new variant Creutzfeldt Jacob disease) |
| Post-transfusion hemosiderosis (iron overload) |
- Citation: García-Erce JA, Gomollón F, Muñoz M. Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009; 15(37): 4686-4694
- URL: https://www.wjgnet.com/1007-9327/full/v15/i37/4686.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4686